Other Information
+Added: 1.1 Sales Agreement, dated August 9, 2022, between Precigen, Inc.
+Added: and Cantor Fitzgerald & Co., originally filed as Exhibit 1.1 to Precigen's Form 8-K filed with the SEC on August 9, 2022, which is incorporated by reference herein
2.1 Membership Interest Purchase Agreement dated July 1, 2022 by and among Precigen, Inc., Trans Ova Genetics, L.C.
7 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: 101** Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended June 30, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language)).
+Added: 101** Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended September 30, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language)).
Attached as Exhibit 101.0 to this Quarterly Report on Form 10-Q are the following documents formatted in XBRL:
−Removed: (i) the Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021, (ii) the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2022 and 2021, (iii) the Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2022 and 2021, (iv) the Condensed Consolidated Statements of Shareholders' Equity for the three and six months ended June 30, 2022 and 2021, (v) the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2022 and 2021, and (vi) the Notes to the Condensed Consolidated Financial Statements.
+Added: (i) the Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021, (ii) the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021, (iii) the Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2022 and 2021, (iv) the Condensed Consolidated Statements of Shareholders' Equity for the three and nine months ended September 30, 2022 and 2021, (v) the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021, and (vi) the Notes to the Condensed Consolidated Financial Statements.
104** Cover Page Interactive Data File (embedded within the Inline XBRL document).
2 unchanged sentences
Precigen, Inc.
−Removed: August 8, 2022 By:
+Added: November 9, 2022 By:
/s/ HARRY THOMASIAN JR.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.